BMJ, doi: 10.1136/bmj.39303.723449.55, (Published 30 August 2007)

Research

Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial

Helen C Eborall, post-doctoral research fellow1, Simon J Griffin, programme leader2, A Toby Prevost, medical statistician1, Ann-Louise Kinmonth, professor of general practice1, David P French, reader in health behaviour interventions3, Stephen Sutton, professor of behavioural science1

1 General Practice and Primary Care Research Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, 2 Medical Research Council Epidemiology Unit, Strangeways Research Laboratory, Cambridge, 3 Applied Research Centre in Health and Lifestyle Interventions, Coventry University, Coventry

Correspondence to: H C Eborall hce21{at}medschl.cam.ac.uk

Objective To quantify the psychological impact of primary care based stepwise screening for type 2 diabetes.

Design Controlled trial and comparative study embedded in a randomised controlled trial.

Setting 15 practices (10 screening, five control) in the ADDITION (Cambridge) trial in the east of England.

Participants 7380 adults (aged 40-69) in the top fourth for risk of having undiagnosed type 2 diabetes (6416 invited for screening, 964 controls).

Interventions Invited for screening for type 2 diabetes or not invited (controls), incorporating a comparative study of subgroups of screening attenders. Attenders completed questionnaires after a random blood glucose test and at 3-6 months and 12-15 months later. Controls were sent questionnaires at corresponding time points. Non-attenders were sent questionnaires at 3-6 months and 12-15 months.

Main outcome measures State anxiety (Spielberger state anxiety inventory), anxiety and depression (hospital anxiety and depression scale), worry about diabetes, and self rated health.

Results No significant differences were found between the screening and control participants at any time—for example, difference in means (95% confidence intervals) for state anxiety after the initial blood glucose test was –0.53, –2.60 to 1.54, at 3-6 months was 1.51 (–0.17 to 3.20), and at 12-15 months was 0.57, –1.11 to 2.24. After the initial test, compared with participants who screened negative, those who screened positive reported significantly poorer general health (difference in means –0.19, –0.25 to –0.13), higher state anxiety (0.93, –0.02 to 1.88), higher depression (0.32, 0.08 to 0.56), and higher worry about diabetes (0.25, 0.09 to 0.41), although effect sizes were small. Small but significant trends were found for self rated health across the screening subgroups at 3-6 months (P=0.047) and for worry about diabetes across the screen negative groups at 3-6 months and 12-15 months (P=0.001).

Conclusions Screening for type 2 diabetes has limited psychological impact on patients. Implementing a national screening programme based on the stepwise screening procedure used in the ADDITION (Cambridge) trial is unlikely to have significant consequences for patients' psychological health.

Trial registration Current Controlled Trials ISRCTN99175498 [controlled-trials.com] .


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Paddison, C. A M, Eborall, H. C, Sutton, S., French, D. P, Vasconcelos, J., Prevost, A T., Kinmonth, A.-L., Griffin, S. J (2009). Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ 339: b4535-b4535 [Abstract] [Full text]  
  • van den Bergh, K. A. M., Essink-Bot, M. L., van Klaveren, R. J., de Koning, H. J. (2009). Informed participation in a randomised controlled trial of computed tomography screening for lung cancer. Eur Respir J 34: 711-720 [Abstract] [Full text]  
  • Agwu, J C. (2008). Screening for type 2 diabetes mellitus in children and adolescents. British Journal of Diabetes & Vascular Disease 8: 163-168 [Abstract]  
  • Barnett, A., Hitman, G., Hughes, E., Khunti, K. (2008). New Perspectives on the Management of Type 2 Diabetes: Report of symposia at the Royal College of Physicians, London, 16 April 2008 and Hilton Hotel, Coventry, 14 May 2008. British Journal of Diabetes & Vascular Disease 8: 198-205  
  • Norris, S. L., Kansagara, D., Bougatsos, C., Fu, R. (2008). Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED 148: 855-868 [Abstract] [Full text]  
  • Balkau, B. (2008). Screening for Diabetes. Diabetes Care 31: 1084-1085 [Full text]  
  • Eborall, H., Davies, R., Kinmonth, A.-L., Griffin, S., Lawton, J. (2007). Patients' experiences of screening for type 2 diabetes: prospective qualitative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ 335: 490-490 [Abstract] [Full text]  
  • Stolk, R. P (2007). Screening for diabetes. BMJ 335: 457-458 [Full text]  

Rapid Responses:

Read all Rapid Responses

Does screening for type 2 diabetes have any negative psychosocial impact?
John Brodersen, et al.
bmj.com, 8 Sep 2007 [Full text]
Do Editors read articles?
Shahid Amin
bmj.com, 10 Sep 2007 [Full text]
Access jobs at BMJ Careers
Whats new online at Student BMJ